Feedback / Questions
lirentelimab (AK002) - Allakos
https://www.globenewswire.com/news-release/2023/06/05/2681832/0/en/Allakos-Announces-Upcoming-Presentation-on-Lirentelimab-and-AK006-Mast-Cell-Inhibition-at-the-European-Academy-of-Allergy-and-Clinical-Immunology-EAACI-Hybrid-Congress-2023.html
Jun 5, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next